Immune-Onc Therapeutics
Charting a New Course in Immunology and Oncology Drug Development.
$131M Series B+ ·
Led by TriWise Capital · Source: startupintros.com
Total raised: $211M across 3 sourced rounds
All 3 rounds ↓Signals
Immune-Onc Therapeutics | 188 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $131M | startupintros.com | ||
| Series B+ | $73M | startupintros.com | ||
| Series A | $7M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
CL
Charlene Liao FounderGL
Guo Liang Yu FounderCW
Christopher Whitmore Chief Financial Officer
Investors
BBOCOM International
NNorthern Light Venture Capital
OOceanpine Capitallead investor
OOctagon Capital Advisors
PProxima Ventures Ltd
- QQianzhan Investment Management
SSphera Global Healthcare Fund
TTao Capital
TTriWise Capitallead investor
VVivo Capital
- WWuXi Biologics
YYanchuang Capital
- YYinglian Health Fund
- ZZhongnan Capital
Companies like Immune-Onc Therapeutics
QQuarry Thera$32M Series A · Jan 2026SSingleron Biotechnologies$100M Series B+ · Nov 2021
OOrakl Oncology$34M Series A · Nov 2026
PPathos$237M Series B+ · Oct 2026
AAbTx$1.95M Seed · Sep 2026
CCORE Biomedicine$21M Series A · Jul 2026
Other companies backed by TriWise Capital
NNeuroXess$105.01M Series B+ · Oct 2026
CChongqing Hanpei Biotechnology$1.41M Seed · Dec 2025XXijia MedicalSeed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immune-onc-therapeutics (get a free API key).